Equities
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.002
  • Today's Change0.001 / 100.00%
  • Shares traded16.92m
  • 1 Year change-99.00%
  • Beta2.4387
Data delayed at least 20 minutes, as of May 31 2024 07:10 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Melodiol Global Health Limited is an Australia-based cannabis company. The Company develops cannabis, hemp-derived and other plant-based therapeutic, nutraceutical, and lifestyle products. The Company distributes pharmaceuticals internationally, specializing in the distribution of medicinal cannabis products across Australasia, and non-cannabis products in the United Kingdom and Europe. It also develops and sells beauty and personal care products, produced using plant-based processes, including under the brands Green Goo, Southern Butter and Good Goo. Its segments include Europe, Canada and Asia Pacific. Its Europe segment includes Health House International Limited (HHI), UK division, which distributes pharmaceutical products, and Creso Pharma Switzerland GmbH, which includes the development and commercialization of its nutraceutical products located in Switzerland. Its Canada segment includes Mernova Medicinal Inc, a producer of cannabis products and sells under the Ritual brand.

  • Revenue in AUD (TTM)19.60m
  • Net income in AUD-35.52m
  • Incorporated2015
  • Employees--
  • Location
    Melodiol Global Health LtdSuite 5 CPC145 Stirling Highway, NedlendsPERTH 6009AustraliaAUS
  • Phone+61 28067-8606
  • Fax+61 89481-4950
  • Websitehttps://www.cresopharma.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Nutritional Growth Solutions Ltd4.50m-4.36m753.68k--------0.1675-0.024-0.0240.0233-0.00111.512.1961.53---145.93---303.09--28.2242.47-96.95-152.300.1888--1.96--1.2641.6131.91------
Holista Colltech Limited5.95m-4.81m1.39m3.00------0.2343-0.0172-0.01720.0213-0.00711.352.494.70---111.49-42.59-347.69-63.5856.6656.37-82.68-39.270.2845-------27.82-5.65-230.77---37.12--
Wellfully Ltd1.31m-1.34m1.48m36.00------1.13-0.003-0.0030.0034-0.00340.3770.31661.57---38.36-175.88---441.8448.61---101.74-266.080.2159-------42.78-5.8712.98--21.75--
Melodiol Global Health Ltd19.60m-35.52m1.65m--------0.084-0.2548-0.37620.1578-0.01720.68744.3510.62---124.57-102.92-387.77-152.3215.38---181.22-348.920.1594-6.711.73--210.1394.60-62.47---46.82--
Hexima Ltd193.85k-753.18k1.67m----0.6564--8.62-0.0045-0.00450.00120.01520.0558--0.2705---21.67-72.85-26.54-193.37-----388.54-213.09----0.00--271.52-19.4380.85------
Hydration Pharmaceuticals Co Ltd15.14m-12.22m3.96m--------0.2618-0.0627-0.06270.0776-0.0021.181.616.60---94.86-79.98-143.75-111.5753.7048.73-80.69-99.531.37-21.481.10--10.3419.2723.61------
Bod Science Ltd3.32m-7.95m4.26m--------1.28-0.0557-0.05570.0235-0.00460.75332.428.05---180.40-94.62-465.66-145.7769.2347.08-239.47-129.480.8319--3.71---34.7023.20-47.10--8.23--
Cambium Bio Ltd-28.22k-366.01k4.60m-----------0.0012-0.0012-0.00009-0.0036-0.039-------50.58-49.44---292.47-------118.34------------60.86------
Zelira Therapeutics Ltd1.62m-36.43m5.33m8.00------3.29-3.23-3.230.148-0.20630.08480.1853.55---193.14-27.71-243.04-28.8182.28---2,278.17-508.480.1488-22.80-----80.95-0.363553.35------
Invex Therapeutics Ltd837.95k-6.01m6.01m----1.14--7.18-0.08-0.080.01120.07050.0521--2.79---37.38---40.06-------717.76------0.00--379.22---96.04------
Terragen Holdings Ltd2.60m-2.53m6.27m----0.9179--2.41-0.0099-0.00990.01010.01850.33640.575811.93---32.71-43.86-39.59-50.1196.6187.96-97.24-173.815.79-347.500.0587--13.6731.2240.19---12.30--
Data as of May 31 2024. Currency figures normalised to Melodiol Global Health Ltd's reporting currency: Australian Dollar AUD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.